CompaniesByCap
ACRS
Aclaris Therapeutics, Inc. (ACRS)
NASDAQ · Healthcare

Aclaris Therapeutics, Inc. Income Statement 2017–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenues
Revenue7.8M18.7M31.2M29.8M6.8M6.5M4.2M6.2M1.7M
Gross Profit5.7M15.9M27.8M25.7M2.0M1.3M172,0003.2M476,000
Profitability
Operating Income-76.4M-141.9M-97.4M-89.9M-89.7M-50.9M-111.1M-84.8M-54.4M
EBITDA-75.9M-141.1M-96.5M-89.1M-88.8M-49.6M-104.6M-82.9M-54.0M
Net Income-64.9M-132.1M-88.5M-86.9M-90.9M-51.0M-161.4M-132.7M-68.5M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)123M77M70M65M57M43M41M41M31M

Aclaris Therapeutics, Inc. Income Statement — FAQ

Aclaris Therapeutics, Inc. (ACRS) income statement over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ACRS's income statement history?

The chart and table above show Aclaris Therapeutics, Inc.'s income statement by year and by quarter, including the growth rate.